Axial Therapeutics is a clinical-stage biopharmaceutical company harnessing the gut–brain axis (G–BA) to develop safe and effective therapies for patients impacted by central nervous system ...
Researchers used a preclinical mouse model to explore whether, and how, K. pneumoniae pathogenesis exacerbates neuropathogenesis via the gut-blood-brain axis. Young mice were infected with K.